retatrutide weight loss clinical trials retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide: What It Is &
Description
GLP-1 |

Retatrutide versus semaglutide The comparison between these two compounds highlights the difference between single and triple agonism

These findings suggest that GLP-1RAs may have beneficial effects on cardiovascular outcomes and coronary artery disease progression in this population
It leaves too much open
The PlexusDx Precision Peptide Genetic Test identifies key genetic markers including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 that affect peptide pathway sensitivity and medication response
